- Molnupiravir – the first antiviral pill for early COVID-19
- Molnupiravir as post-exposure prophylaxis against COVID-19
- Fluvoxamine – generic antidepressant looks very promising in treating early COVID
- Other oral antivirals under development for COVID-19
- CATIE News• A U.S. study has found that certain health conditions appear to increase the risk for frailty
• These conditions were stroke, diabetes, lung and liver disease
• Screening, preventing… - WHY SCS is a project of the Canadian Research Initiative in Substance Misuse (CRISM). The WHY SCS team works with substance use researchers, people with lived and/or living experience of substance…
- Programming ConnectionThe Anonymous HIV Testing Program in London, Ontario, provides HIV prevention, testing and counselling services to at-risk populations on an outreach basis in and around the city.